🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 w...
Status
Unknown
Location
University of Arizona
Start Date
2018-10-11
Trial ID
NCT03567720
Treatments Being Tested
This is a multicenter, Phase II, open-label, 42-patient single-arm trial of...
Status
Completed
Location
University of San Francisco, California
Start Date
2015-08-17
Trial ID
NCT02493361
Treatments Being Tested
This phase II trial studies the effectiveness of ImmunoPulse IL-12® in trea...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-01-03
Trial ID
NCT01440816
Treatments Being Tested
Participant with squamous cell cancer of head and neck are invited to parti...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
1999-07
Trial ID
NCT00004070
Treatments Being Tested
Background: \- One experimental treatment for certain types of cancer is c...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-10
Trial ID
NCT01236573
Treatments Being Tested
Keynote 695 is Phase 2 study of intratumoral tavokinogene telseplasmid (tav...
Status
Unknown
Location
The University of Arizona Cancer Center
Start Date
2017-10-03
Trial ID
NCT03132675
Treatments Being Tested
This is a Phase 1, open-label study to evaluate the safety profile of CORVa...
Status
Terminated
Location
Providence Portland Medical Center
Start Date
2020-12-30
Trial ID
NCT04627675
Treatments Being Tested
RATIONALE: Inserting the gene for interleukin-12 into a person's skin tumor...
Status
Terminated
Location
University of Wisconsin Comprehensive Cancer Center
Start Date
2002-01
Trial ID
NCT00028652
Treatments Being Tested
This is a two part study to evaluate the immunogenicity and tolerability of...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-15
Trial ID
NCT03663998
Treatments Being Tested
This phase II trial studies how well tavokinogene telseplasmid with electro...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-05-02
Trial ID
NCT03823131
Treatments Being Tested